Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1200/JCO.23.00502 | DOI Listing |
J Natl Cancer Inst
November 2024
Department of Urology, University of Washington Medical Center, Seattle WA, USA.
Black individuals are less likely to be treated for prostate cancer even though they are more than twice as likely to die compared to White individuals. The complex causes of these inequities are influenced by social and structural factors, including racism, which contribute to the differential delivery of care. This study investigates how factors related to the location of where individuals live and receive care affect treatment inequities for prostate cancer between Black and White individuals.
View Article and Find Full Text PDFNat Rev Urol
October 2024
Department of Radiation Oncology, Dana-Farber Cancer Institute/Harvard Cancer Center, Boston, MA, USA.
In the USA, Black men are approximately twice as likely to be diagnosed with and to die of prostate cancer than white men. In the UK, despite Black men having vastly different ancestral contexts and health-care systems from Black men in the USA, the lifetime risk of being diagnosed with prostate cancer is two-to-three times higher among Black British men than among white British men and Black British men are twice as likely to die of prostate cancer as white British men. Examination of racial disparities in prostate cancer in the USA and UK highlights systemic, socio-economic and sociocultural factors that might contribute to these differences.
View Article and Find Full Text PDFCureus
July 2024
Renal Transplantation Unit, Laiko General Hospital, Athens, GRC.
J Racial Ethn Health Disparities
July 2024
Department of Health Sciences, Crean College of Health and Behavioral Sciences, Chapman University, One University Drive, Orange, CA, USA.
Unlabelled: Prostate cancer is the second leading cause of death for men in the U.S. and Black men are twice as likely to die from the disease.
View Article and Find Full Text PDFCancer Epidemiol Biomarkers Prev
March 2024
Department of Urology, University of Washington Medical Center, Seattle, Washington.
Background: Black individuals in the United States are less likely than White individuals to receive curative therapies despite a 2-fold higher risk of prostate cancer death. While research has described treatment inequities, few studies have investigated underlying causes.
Methods: We analyzed a cohort of 40,137 Medicare beneficiaries (66 and older) linked to the Surveillance Epidemiology and End Results (SEER) cancer registry who had clinically significant, non-metastatic (cT1-4N0M0, grade group 2-5) prostate cancer (diagnosed 2010-2015).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!